KRAS Inhibitor Regimen Approved for Colorectal Cancer
The FDA issued its first approval for the use of A KRAS G12C inhibitor in a tumor type other...
American Association for Cancer Research Inaugurates New Leadership During AACR Annual Meeting 2024
Patricia M. LoRusso, DO, PhD (hc), FAACR, begins term as AACR President SAN DIEGO – The members of the...
Patricia M. LoRusso, DO, PhD (hc), Elected as American Association for Cancer Research President-Elect for 2023-2024
Five new members elected to the Board of Directors PHILADELPHIA – The members of the American Association for Cancer...
Lillian L. Siu, MD, FAACR, Elected as American Association for Cancer Research President-Elect for 2024-2025
Five new members elected to the Board of Directors PHILADELPHIA – The members of the American Association for Cancer...
AACR Announces 2024 Scientific Achievement Award Recipients
Awardees to be recognized at the AACR Annual Meeting 2024 in San Diego PHILADELPHIA – The American Association for...
AACR to Recognize Chi Van Dang, MD, PhD, FAACR, with 2024 AACR-Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will honor Chi Van Dang, MD, PhD, Fellow of the...
AACR Announces 2024 Distinguished Public Service Award Recipients
PHILADELPHIA – The American Association for Cancer Research (AACR) will present the 2024 AACR Distinguished Public Service Award for...
American Association for Cancer Research Inaugurates New Leadership at the AACR Annual Business Meeting of Members 2023
Philip D. Greenberg, MD, FAACR, Inaugurated as President PHILADELPHIA – The members of the American Association for Cancer Research...
AACR Announces Newly Elected 2024 Class of Fellows of the AACR Academy
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced its newly elected class of Fellows of the...
Call for Submissions: 2024 AACR June L. Biedler Prize for Cancer Journalism
Awardees will receive $5,000 unrestricted cash prize PHILADELPHIA – The American Association for Cancer Research (AACR) is inviting journalists...
AACR Announces Recipients of the 2024 AACR June L. Biedler Prize for Cancer Journalism
PHILADELPHIA – The American Association for Cancer Research (AACR) is pleased to announce the recipients of the 2024 AACR...
AACR Chief Philanthropic Officer Mitch Stoller to Receive 2024 Change Our Future Game Changer Award
Stoller will be recognized tonight at the 4th annual Sneaker Ball, hosted by former Eagle Rodney McLeod Jr. and...
Pfizer Chairman and CEO Dr. Albert Bourla to Receive the 2024 AACR Outstanding Achievement Award for Service to Cancer Science and Medicine
The American Association for Cancer Research (AACR) will honor Pfizer Inc., as well as Pfizer’s chairman and chief executive...
Titia de Lange, PhD, FAACR, Selected for 2024 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research
PHILADELPHIA – The Pezcoller Foundation–American Association for Cancer Research (AACR) International Award for Extraordinary Achievement in Cancer Research will...
Rafi Ahmed, PhD, to Present 2024 AACR-Irving Weinstein Foundation Distinguished Lecture
PHILADELPHIA — The American Association for Cancer Research (AACR) will award the 20th AACR-Irving Weinstein Foundation Distinguished Lectureship to...
Steven A. Rosenberg, MD, PhD, FAACR, Honored with 2024 AACR Award for Lifetime Achievement in Cancer Research
PHILADELPHIA – The American Association for Cancer Research (AACR) will award Steven A. Rosenberg, MD, PhD, Fellow of the...
Gordon J. Freeman, PhD, FAACR, Recognized with 2024 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology
PHILADELPHIA – The American Association for Cancer Research (AACR) will award Gordon J. Freeman, PhD, FAACR, with the 2024...
Lisa M. Coussens, PhD, FAACR, Elected as American Association for Cancer Research President-Elect for 2021-2022
Five new members elected to the Board of Directors PHILADELPHIA — The members of the American Association for Cancer...
Four New Institutions Join AACR Project GENIE® Consortium
PHILADELPHIA — To further its commitment to diversity, equity, and inclusion, the American Association for Cancer Research (AACR) has...
AZD1390 With Radiotherapy Shows Manageable Safety Profile and Preliminary Efficacy for Patients with Glioblastoma in Phase I Trial
SAN DIEGO – AZD1390, an ataxia telangiectasia mutant (ATM) kinase inhibitor, demonstrated a manageable safety profile in both recurrent...
Culturally Sensitive Video Targeting Black Men May Help Increase Awareness About Prostate Cancer
SAN DIEGO – A video designed to educate Black men about prostate cancer resulted in 97% of surveyed participants...
Immune Response to Investigational RNA Vaccine for Pancreatic Cancer Continues to Correlate with Clinical Benefit
Results are from a median follow-up of three years SAN DIEGO – An adjuvant treatment regimen that included autogene...
Bispecific Immune Checkpoint Inhibitor Improves Survival in Gastric Cancer Patients Regardless of PD-L1 Status
SAN DIEGO – The PD-1/CTLA-4 bispecific antibody cadonilimab plus chemotherapy improved progression-free survival and overall survival in patients with...
Accelerated Aging May Increase the Risk of Early-onset Cancers in Younger Generations
SAN DIEGO – Accelerated aging was more common in recent birth cohorts and was associated with increased incidence of...
Fewer Than Half of Accelerated Approval Drugs Showed Clinical Benefit in Confirmatory Trials After Five Years
SAN DIEGO – Of the 46 cancer drugs that the U.S. Food and Drug Administration (FDA) granted accelerated approval...
A Biologic Drug-Device Combination Immunotherapy Shows Promise for Patients with Metastatic Prostate Cancer
The investigational therapy uses a cold-temperature probe to kill a portion of prostate cancer cells and release tumor-specific neoantigens...
Adagrasib Plus Cetuximab May Provide Clinical Benefit in Patients With KRASG12C-mutated Colorectal Cancer
SAN DIEGO – A combination of the KRASG12C inhibitor adagrasib (Krazati) and the anti-epidermal growth factor receptor (EGFR) antibody...
Next-generation PARP Inhibitor Demonstrates Clinical Benefit in Patients with Homologous Recombination Repair-deficient Breast Cancer
Drug has higher selectivity for PARP1, improving safety and tolerability SAN DIEGO – Saruparib, a selective inhibitor of poly-ADP...
An Exosome-based Liquid Biopsy Shows Promise for Early Detection of Pancreatic Cancer
SAN DIEGO – An investigational exosome-based liquid biopsy accurately detected 97% of stage 1-2 pancreatic cancers when combined with...
Media Registration Now Open: AACR Annual Meeting 2024, April 5-10
SAN DIEGO – The American Association for Cancer Research (AACR) will host its 115th Annual Meeting from April 5-10, 2024,...